Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Jalal A. Aram"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Isavuconazole is a triazole with broad-spectrum antifungal activity. In this post-hoc analysis of two prospective clinical trials (VITAL and SECURE), the safety and efficacy of isavuconazole in patients aged ≥ 65 years with invasive fungal
Externí odkaz:
https://doaj.org/article/39a775a2183544f8ab2bd52af6c9620e
Autor:
Yang Ping, Jing Hongmei, Christian Bellmann, Mónica Inês, Tom Macmillan, Neil Webb, Jalal A. Aram, Olaf Penack
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 723-732 (2022)
Objectives Patients with haematologic malignancies are at high risk of developing invasive fungal infections (IFIs). Current guidelines recommend the use of azoles for IFI prophylaxis; however, in many clinical situations, antifungal prophylaxis is u
Externí odkaz:
https://doaj.org/article/8972577acdb141fbb1953d80b2dd9dde
Autor:
Yayue Zhang, Anita H. Sung, Emily Rubinstein, Michael Benigno, Richard Chambers, Nataly Patino, Jalal A. Aram
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Invasive mucormycosis (IM) is a rare and often life-threatening fungal infection, for which clinical and epidemiological understanding is lacking. Electronic health record (EHR) data can be utilized to elucidate large populations
Externí odkaz:
https://doaj.org/article/b06c9c229d6649eca37c58c3d60d82b1
Autor:
Jie Jin, Depei Wu, Yang Liu, Sisi Pan, Jean Li Yan, Jalal A. Aram, Yin-jun Lou, Haitao Meng, Xiaochen Chen, Xian’an Zhang, Ilan S. Schwartz, Thomas F. Patterson
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Pulmonary computed tomography (CT) scans are commonly used as part of the clinical criteria in diagnostic workup of invasive fungal diseases like invasive aspergillosis, and may identify radiographic abnormalities, such as halo si
Externí odkaz:
https://doaj.org/article/bead5b81c75546579f6664863844555e
Autor:
Anita H, Sung, Stephan, Martin, Bryant, Phan, Michael, Benigno, Jennifer, Stephens, Jalal A, Aram
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Introduction Diagnosis and treatment of invasive mold infections (IMI) can be challenging and IMI is a significant source of morbidity and mortality. Invasive aspergillosis (IA) and invasive mucormycosis (IM) are two of the most common mold infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb9ccf849b496f90e9e3b4ed1e6d12b2
https://doi.org/10.2217/fmb-2022-0144
https://doi.org/10.2217/fmb-2022-0144
Autor:
Ran Jing, Ian Morrissey, Meng Xiao, Tian-Shu Sun, Ge Zhang, Kang Wei, Da-Wen Guo, Jalal A Aram, Jeffrey Wang, Eric A Utt, Yao Wang, Ying-Chun Xu
Publikováno v:
Future microbiology.
What is this summary about? Molds are types of fungus that can cause sickness and death. Mold infections are increasing in China. Until 2022, medicines that can effectively treat all mold infections were still lacking in China. This summary of a stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30dd79be26ddb6c5b1ba131d2234fc94
https://pubmed.ncbi.nlm.nih.gov/36511165
https://pubmed.ncbi.nlm.nih.gov/36511165
Autor:
Bryant Phan, Michael Benigno, Stephan Martin, Jalal A. Aram, Anita H Sung, Jennifer Stephens, Richard Chambers
Publikováno v:
ClinicoEconomics and Outcomes Research. 13:593-602
Anita H Sung,1 Stephan Martin,2 Bryant Phan,1 Michael Benigno,1 Jennifer Stephens,2 Richard Chambers,1 Jalal A Aram1 1Pfizer Inc, New York, NY, USA; 2OPEN Health, Bethesda, MD, USACorrespondence: Anita H SungPfizer, 235 E 42nd St, New York, NY, 10017
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b453f5dc1570c58910e2054baaa997
https://doi.org/10.2147/ceor.s308744
https://doi.org/10.2147/ceor.s308744
Autor:
Yingyuan Zhang, Depei Wu, Rana Fayyad, Jing Zhang, Guoying Cao, Xuan Guo, Amit Desai, Kamal Hamed, Oliver A. Cornely, Jalal A. Aram
Publikováno v:
Mycoses. 64:445-456
Background Isavuconazole is a broad-spectrum triazole for the treatment of invasive fungal disease (IFD). Objective To investigate the clinical experience with isavuconazole in Chinese individuals. Patients/methods Participants were Chinese healthy v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::158c37afc7f3ea57b280c63f9a784654
https://doi.org/10.1111/myc.13233
https://doi.org/10.1111/myc.13233
Autor:
Ran Jing, Ian Morrissey, Meng Xiao, Tian-Shu Sun, Ge Zhang, Wei Kang, Da-Wen Guo, Jalal A Aram, Jeffrey Wang, Eric A Utt, Yao Wang, Ying-Chun Xu
Publikováno v:
Infection and Drug Resistance.
Ran Jing,1â 3 Ian Morrissey,4 Meng Xiao,1,3 Tian-Shu Sun,3,5 Ge Zhang,1,3 Wei Kang,1,3 Da-Wen Guo,6 Jalal A Aram,7 Jeffrey Wang,8 Eric A Utt,7 Yao Wang,1,3 Ying-Chun Xu1â 3 1Department of Laboratory Medicine, State Key Laboratory of Complex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86dac075302bed1677d6a86a7ed15ec3
https://www.dovepress.com/in-vitro-activity-of-isavuconazole-and-comparators-against-clinical-is-peer-reviewed-fulltext-article-IDR
https://www.dovepress.com/in-vitro-activity-of-isavuconazole-and-comparators-against-clinical-is-peer-reviewed-fulltext-article-IDR
Autor:
Thomas S. McCormick, Ahmed Gamal, Janet Herrada, Lisa Long, Jalal A. Aram, Mahmoud A. Ghannoum
Publikováno v:
Antimicrob Agents Chemother
Antifungal activity of anidulafungin, voriconazole, isavuconazole, and fluconazole in the treatment of Candida auris was determined in vitro and in vivo. Minimum inhibitory concentrations (MICs) for Anidulafungin, voriconazole, isavuconazole, flucona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e937c2c245e53dbab9508ce1a0752cc
https://pubmed.ncbi.nlm.nih.gov/34228541
https://pubmed.ncbi.nlm.nih.gov/34228541